Jinchul Kim

1.3k total citations
31 papers, 633 citations indexed

About

Jinchul Kim is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jinchul Kim has authored 31 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jinchul Kim's work include CAR-T cell therapy research (6 papers), Gastric Cancer Management and Outcomes (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Jinchul Kim is often cited by papers focused on CAR-T cell therapy research (6 papers), Gastric Cancer Management and Outcomes (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Jinchul Kim collaborates with scholars based in South Korea, United States and China. Jinchul Kim's co-authors include Jinhyun Cho, Yang Xu, Bingbing Feng, Lei Jiang, Qingshuang Tang, Xuemei Fu, Wancheng Chen, Ulrich Siebenlist, María I. Morasso and Mark C. Udey and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Blood.

In The Last Decade

Jinchul Kim

28 papers receiving 625 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinchul Kim South Korea 10 243 234 175 159 123 31 633
W Famulski Poland 15 248 1.0× 251 1.1× 92 0.5× 128 0.8× 50 0.4× 59 604
Hong Nie China 11 338 1.4× 339 1.4× 245 1.4× 111 0.7× 86 0.7× 15 776
Kue Peng Lim Malaysia 14 382 1.6× 282 1.2× 183 1.0× 176 1.1× 78 0.6× 26 745
Mark J. Sinnamon United States 10 297 1.2× 180 0.8× 201 1.1× 137 0.9× 66 0.5× 12 625
Yu‐zhong Duan China 12 306 1.3× 320 1.4× 263 1.5× 201 1.3× 107 0.9× 26 713
Vera Balz Germany 17 331 1.4× 364 1.6× 192 1.1× 145 0.9× 49 0.4× 38 838
Danh Tran‐Thanh Canada 13 227 0.9× 197 0.8× 38 0.2× 132 0.8× 186 1.5× 28 623
Tserenchunt Gansukh Germany 14 278 1.1× 313 1.3× 77 0.4× 125 0.8× 88 0.7× 17 729
Qingyang Gu China 13 350 1.4× 235 1.0× 62 0.4× 151 0.9× 114 0.9× 26 666
J F Flores United States 9 552 2.3× 565 2.4× 123 0.7× 236 1.5× 73 0.6× 11 968

Countries citing papers authored by Jinchul Kim

Since Specialization
Citations

This map shows the geographic impact of Jinchul Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinchul Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinchul Kim more than expected).

Fields of papers citing papers by Jinchul Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinchul Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinchul Kim. The network helps show where Jinchul Kim may publish in the future.

Co-authorship network of co-authors of Jinchul Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Jinchul Kim. A scholar is included among the top collaborators of Jinchul Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinchul Kim. Jinchul Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Kim, Jinchul, Jinhyun Cho, Moon Hee Lee, et al.. (2024). CAR T cells vs bispecific antibody as third- or later-line large B-cell lymphoma therapy: a meta-analysis. Blood. 144(6). 629–638. 22 indexed citations
4.
5.
Kim, Jinchul, Jinhyun Cho, Sang Eun Yoon, Won Seog Kim, & Seok Jin Kim. (2023). Efficacy of Salvage Treatments in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Including Chimeric Antigen Receptor T-Cell Therapy: A Systematic Review and Meta-Analysis. Cancer Research and Treatment. 55(3). 1031–1047. 6 indexed citations
6.
Lee, Jeong-Woong, Dong‐Hwan Kim, Jangwook Lee, et al.. (2022). KLHL3 deficiency in mice ameliorates obesity, insulin resistance, and nonalcoholic fatty liver disease by regulating energy expenditure. Experimental & Molecular Medicine. 54(8). 1250–1261. 3 indexed citations
7.
Yu, Lili, Lei Jiang, Meng Wu, et al.. (2022). RNA helicase MTR4 drives tumorigenesis of nasopharyngeal carcinoma by regulating the expression of key cell cycle genes. Protein & Cell. 14(2). 149–152. 2 indexed citations
8.
Kim, Jinchul, Seonggyu Byeon, Kee‐Taek Jang, et al.. (2021). Programmed Death Ligand 1 Expression as a Prognostic Marker in Patients with Advanced Biliary Tract Cancer. Oncology. 99(6). 365–372. 9 indexed citations
9.
10.
Byeon, Seonggyu, Jinchul Kim, Minsuk Kwon, et al.. (2020). Docetaxel rechallenge in metastatic castration-resistant prostate cancer: A retrospective, single-center study. Investigative and Clinical Urology. 61(6). 588–588. 4 indexed citations
11.
Kim, Jinchul, Binnari Kim, So Young Kang, et al.. (2020). Tumor Mutational Burden Determined by Panel Sequencing Predicts Survival After Immunotherapy in Patients With Advanced Gastric Cancer. Frontiers in Oncology. 10. 314–314. 61 indexed citations
12.
Kim, Jinchul, Jung Yong Hong, Seung Tae Kim, et al.. (2020). Clinical scoring system for the prediction of survival of patients with advanced gastric cancer. ESMO Open. 5(2). e000670–e000670. 17 indexed citations
13.
Kim, Jinchul, Seonggyu Byeon, Jung Yong Hong, et al.. (2020). Impact of Prior Ramucirumab Use on Treatment Outcomes of Checkpoint Inhibitors in Advanced Gastric Cancer Patients. Targeted Oncology. 15(2). 203–209. 1 indexed citations
14.
Lee, Young Eun, Anna Ju, Jinchul Kim, et al.. (2020). Rationally designed redirection of natural killer cells anchoring a cytotoxic ligand for pancreatic cancer treatment. Journal of Controlled Release. 326. 310–323. 43 indexed citations
15.
Kim, Jinchul, Hana Kim, Jung Yong Hong, et al.. (2020). Prognostic Factors of Survival with Aflibercept and FOLFIRI (fluorouracil, leucovorin, irinotecan) as Second-line Therapy for Patients with Metastatic Colorectal Cancer. Journal of Cancer. 12(2). 460–466. 4 indexed citations
16.
17.
Kim, Jinchul, et al.. (2019). Effect of study-level factors on treatment-free remission rate in patients with chronic myeloid leukemia: a systematic review and meta-analysis. International Journal of Hematology. 110(6). 683–689. 10 indexed citations
18.
Kim, Jinchul, Lili Yu, Wancheng Chen, et al.. (2019). Wild-Type p53 Promotes Cancer Metabolic Switch by Inducing PUMA-Dependent Suppression of Oxidative Phosphorylation. Cancer Cell. 35(2). 191–203.e8. 144 indexed citations
19.
Kim, Jinchul, Jinhyun Cho, Moon Hee Lee, & Joo Han Lim. (2018). Relative Efficacy of Checkpoint Inhibitors for Advanced NSCLC According to Programmed Death-Ligand-1 Expression: A Systematic Review and Network Meta-Analysis. Scientific Reports. 8(1). 11738–11738. 21 indexed citations
20.
Kim, Jinchul, et al.. (2008). Intraviteal Bevacizumab (Avastin®) Injection for the Treatment of Early-Stage Neovascular Glaucoma. Journal of the Korean Ophthalmological Society. 49(4). 696–696. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W Famulski Breakdown of academic impact, for papers by Hong Nie Breakdown of academic impact, for papers by Kue Peng Lim Breakdown of academic impact, for papers by Mark J. Sinnamon Breakdown of academic impact, for papers by Yu‐zhong Duan Breakdown of academic impact, for papers by Vera Balz Breakdown of academic impact, for papers by Danh Tran‐Thanh Breakdown of academic impact, for papers by Tserenchunt Gansukh Breakdown of academic impact, for papers by Qingyang Gu Breakdown of academic impact, for papers by J F Flores
Rankless by CCL
2026